In this regard, we aimed to investigate the correlation of A2AR with PD-1 and CTLA-4 regulatory proteins to identify the potential interplay between these immunological pathways and consequently emphasize the relevance of combined therapy in human breast cancer. Here, CTLA4 is linked to breast cancer.